Bristol Myers Squibb (CELG-RI) Inventory Average (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has reported Inventory Average for 17 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 1.67% year-over-year to $2.7 billion in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 1.67% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 0.54% from the prior year.
• Inventory Average was $2.7 billion for Q2 2026 at Bristol Myers Squibb, up from $2.7 billion in the prior quarter.
• Over five years, Inventory Average peaked at $3.2 billion in Q3 2024 and troughed at $2.1 billion in Q1 2022.
• A 5-year average of $2.6 billion and a median of $2.7 billion in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 33.52% in 2024 and retreated 14.26% in 2025, its largest moves.
• Over 5 years, Inventory Average stood at $2.2 billion in 2022, then advanced by 15.52% to $2.5 billion in 2023, then grew by 15.52% to $2.9 billion in 2024, then declined by 7.49% to $2.7 billion in 2025, then increased by 0.83% to $2.7 billion in 2026.
• The last three Inventory Average figures came in at $2.7 billion (Q2 2026), $2.7 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.